Back
Medical Properties Trust 10K Form
Buy
57
MPW
Medical Properties Trust
Last Price:
$5.99
Seasonality Move:
5.06%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-05-29 | 10Q | MPW/Medical Properties Trust Quarterly |
2023-11-09 | 10Q | MPW/Medical Properties Trust Quarterly |
2023-08-09 | 10Q | MPW/Medical Properties Trust Quarterly |
2023-05-10 | 10Q | MPW/Medical Properties Trust Quarterly |
2022-11-09 | 10Q | MPW/Medical Properties Trust Quarterly |
2022-08-09 | 10Q | MPW/Medical Properties Trust Quarterly |
Receive MPW News And Ratings
See the #1 stock for the next 7 days that we like better than MPW
MPW Financial Statistics
Sales & Book Value
Annual Sales: | $995.5M |
---|---|
Cash Flow: | $76.7M |
Price / Cash Flow: | 14.62 |
Annual Sales: | $8.05 |
Price / Book: | 0.74 |
Profitability
EPS (TTM): | -4.03000 |
---|---|
Net Income (TTM): | $-2.4B |
Gross Margin: | $968.3M |
Return on Equity: | -39.12% |
Return on Assets: | -14.82% |
Medical Properties Trust Earnings Forecast
Key Medical Properties Trust Financial Ratios
-
The Gross Profit Margin over the past 18 years for MPW is 97.26%.
-
The Selling, General & Administrative Expenses for MPW have been equal to 13.44% of Gross Profit Margin.
-
The Net Earning history of MPW is -242.11% of Total Revenues.
-
Per Share Earnings over the last 21 years have been positive in 10 years.
Medical Properties Trust Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NYSE |
---|---|
Industry: | Health Care REITs |
Sector: | Real Estate |
Current Symbol: | MPW |
CUSIP: | 58463J |
Website: | medicalpropertiestrust.com |
Debt
Debt-to-Equity Ratio: | 1.83 |
---|---|
Current Ratio: | 1.55 |
Quick Ratio: | 1.39 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 9.82 |
MPW Technical Analysis vs Fundamental Analysis
Buy
57
Medical Properties Trust (MPW)
is a Buy
Is Medical Properties Trust a Buy or a Sell?
-
Medical Properties Trust stock is rated a BuyThe current Medical Properties Trust [MPW] share price is $5.98. The Score for MPW is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.